Anika Therapeutics, Inc. (ANIK) Revenue Growth
Anika Therapeutics, Inc. (ANIK) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2017-12-31 | 9.71% |
| 2018-12-31 | -6.93% |
| 2019-12-31 | 8.58% |
| 2020-12-31 | 13.83% |
| 2021-12-31 | 13.29% |
| 2022-12-31 | 5.71% |
| 2023-12-31 | -22.69% |
| 2024-12-31 | -0.73% |
| 2025-12-31 | -5.91% |
How ANIK compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| ABT | Abbott Laboratories | 5.67% |
| TMO | Thermo Fisher Scientific Inc | 3.91% |
| AZTA | Azenta Inc. | 3.55% |
| GILD | Gilead Sciences Inc. | 2.40% |
| REGN | Regeneron Pharmaceuticals Inc. | 0.99% |
These are five companies in the same sector as ANIK with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Anika Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("ANIK", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | ANIK | $20.81 | -0.90% | 0.10M |
| 3 | ||||
| 4 | ||||
| 5 |